106 related articles for article (PubMed ID: 2696688)
1. Oncogene cooperation and B-lymphoid tumorigenesis in Emu-myc transgenic mice.
Alexander WS; Bernard O; Langdon WY; Harris AW; Adams JM; Cory S
Haematol Blood Transfus; 1989; 32():423-7. PubMed ID: 2696688
[No Abstract] [Full Text] [Related]
2. Acceleration of B-lymphoid tumorigenesis in E mu-myc transgenic mice by v-H-ras and v-raf but not v-abl.
Langdon WY; Harris AW; Cory S
Oncogene Res; 1989; 4(4):253-8. PubMed ID: 2549487
[TBL] [Abstract][Full Text] [Related]
3. MoMuLV proviral integrations identified by Sup-F selection in tumors from infected myc/pim bitransgenic mice correlate with activation of the gfi-1 gene.
Schmidt T; Zörnig M; Beneke R; Möröy T
Nucleic Acids Res; 1996 Jul; 24(13):2528-34. PubMed ID: 8692692
[TBL] [Abstract][Full Text] [Related]
4. Lymphomagenesis in E mu-myc transgenic mice can involve ras mutations.
Alexander WS; Bernard O; Cory S; Adams JM
Oncogene; 1989 May; 4(5):575-81. PubMed ID: 2657573
[TBL] [Abstract][Full Text] [Related]
5. Isolation of a new human oncogene from a diffuse B-cell lymphoma.
Eva A; Aaronson SA
Nature; 1985 Jul 18-24; 316(6025):273-5. PubMed ID: 3875039
[TBL] [Abstract][Full Text] [Related]
6. v-myc and v-raf act synergistically to induce B-cell tumors in pristane-primed adult BALBC mice.
Kurie JM; Morse HC; Principato MA; Wax JS; Troppmair J; Rapp UR; Potter M; Mushinski JF
Oncogene; 1990 Apr; 5(4):577-82. PubMed ID: 2183159
[TBL] [Abstract][Full Text] [Related]
7. Novel primitive lymphoid tumours induced in transgenic mice by cooperation between myc and bcl-2.
Strasser A; Harris AW; Bath ML; Cory S
Nature; 1990 Nov; 348(6299):331-3. PubMed ID: 2250704
[TBL] [Abstract][Full Text] [Related]
8. Abelson murine leukemia virus transforms preneoplastic Emu-myc transgene-carrying cells of the B-lymphocyte lineage into plasmablastic tumors.
Sugiyama H; Silva S; Wang YS; Weber G; Babonits M; Rosén A; Wiener F; Klein G
Int J Cancer; 1990 Nov; 46(5):845-52. PubMed ID: 2228313
[TBL] [Abstract][Full Text] [Related]
9. Retroviral infection accelerates T lymphomagenesis in E mu-N-ras transgenic mice by activating c-myc or N-myc.
Haupt Y; Harris AW; Adams JM
Oncogene; 1992 May; 7(5):981-6. PubMed ID: 1570158
[TBL] [Abstract][Full Text] [Related]
10. Expression of the 6C3 antigen on murine hematopoietic neoplasms. Association with expression of abl, ras, fes, src, erbB, and Cas NS-1 oncogenes but not with myc.
Morse HC; Tidmarsh GF; Holmes KL; Frederickson TF; Hartley JN; Pierce JH; Langdon WY; Dailey MO; Weissman IL
J Exp Med; 1987 Mar; 165(3):920-5. PubMed ID: 3493323
[TBL] [Abstract][Full Text] [Related]
11. Hemopoietic lineage switch: v-raf oncogene converts Emu-myc transgenic B cells into macrophages.
Klinken SP; Alexander WS; Adams JM
Cell; 1988 Jun; 53(6):857-67. PubMed ID: 2454746
[TBL] [Abstract][Full Text] [Related]
12. Pim-2 transgene induces lymphoid tumors, exhibiting potent synergy with c-myc.
Allen JD; Verhoeven E; Domen J; van der Valk M; Berns A
Oncogene; 1997 Sep; 15(10):1133-41. PubMed ID: 9294606
[TBL] [Abstract][Full Text] [Related]
13. Combined loss of PUMA and p21 accelerates c-MYC-driven lymphoma development considerably less than loss of one allele of p53.
Valente LJ; Grabow S; Vandenberg CJ; Strasser A; Janic A
Oncogene; 2016 Jul; 35(29):3866-71. PubMed ID: 26640149
[TBL] [Abstract][Full Text] [Related]
14. The transgenic window on lymphoid malignancy.
Adams JM; Harris AW; Vaux DL; Alexander WS; Rosenbaum H; Klinken SP; Strasser A; Bath ML; McNeall J; Cory S
Princess Takamatsu Symp; 1989; 20():297-309. PubMed ID: 2518688
[TBL] [Abstract][Full Text] [Related]
15. Pertubation of B and T cell development and predisposition to lymphomagenesis in Emu Bmi1 transgenic mice require the Bmi1 RING finger.
Alkema MJ; Jacobs H; van Lohuizen M; Berns A
Oncogene; 1997 Aug; 15(8):899-910. PubMed ID: 9285685
[TBL] [Abstract][Full Text] [Related]
16. A human immunoglobulin gene reduces the incidence of lymphomas in c-Myc-bearing transgenic mice.
Nussenzweig MC; Schmidt EV; Shaw AC; Sinn E; Campos-Torres J; Mathey-Prevot B; Pattengale PK; Leder P
Nature; 1988 Dec; 336(6198):446-50. PubMed ID: 3143076
[TBL] [Abstract][Full Text] [Related]
17. Oncogenic potential of cyclin E in T-cell lymphomagenesis in transgenic mice: evidence for cooperation between cyclin E and Ras but not Myc.
Karsunky H; Geisen C; Schmidt T; Haas K; Zevnik B; Gau E; Möröy T
Oncogene; 1999 Dec; 18(54):7816-24. PubMed ID: 10618723
[TBL] [Abstract][Full Text] [Related]
18. The c-myc oncogene driven by immunoglobulin enhancers induces lymphoid malignancy in transgenic mice.
Adams JM; Harris AW; Pinkert CA; Corcoran LM; Alexander WS; Cory S; Palmiter RD; Brinster RL
Nature; 1985 Dec 12-18; 318(6046):533-8. PubMed ID: 3906410
[TBL] [Abstract][Full Text] [Related]
19. Transformation and plasmacytoid differentiation of EBV-infected human B lymphoblasts by ras oncogenes.
Seremetis S; Inghirami G; Ferrero D; Newcomb EW; Knowles DM; Dotto GP; Dalla-Favera R
Science; 1989 Feb; 243(4891):660-3. PubMed ID: 2536954
[TBL] [Abstract][Full Text] [Related]
20. The functional basis of c-myc and bcl-2 complementation during multistep lymphomagenesis in vivo.
Marin MC; Hsu B; Stephens LC; Brisbay S; McDonnell TJ
Exp Cell Res; 1995 Apr; 217(2):240-7. PubMed ID: 7698223
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
